Viral Hepatitis

You have full text access to this OnlineOpen article

Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame

  1. Hideki Aizaki1,
  2. Takashi Harada1,†,
  3. Motoyuki Otsuka2,
  4. Naohiko Seki3,
  5. Mami Matsuda1,
  6. Yue Wei Li1,
  7. Hayato Kawakami4,
  8. Yoshiharu Matsuura5,
  9. Tatsuo Miyamura1,
  10. Tetsuro Suzuki Ph.D.1,*

Article first published online: 7 MAR 2007

DOI: 10.1002/hep.1840360620

Issue

Hepatology

Hepatology

Volume 36, Issue 6, pages 1431–1438, December 2002

Additional Information

How to Cite

Aizaki, H., Harada, T., Otsuka, M., Seki, N., Matsuda, M., Li, Y. W., Kawakami, H., Matsuura, Y., Miyamura, T. and Suzuki, T. (2002), Expression profiling of liver cell lines expressing entire or parts of hepatitis C virus open reading frame. Hepatology, 36: 1431–1438. doi: 10.1002/hep.1840360620

Author Information

  1. 1

    Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan

  2. 2

    Department of Gastroenterology, Faculty of Medicine, University of Tokyo, Tokyo, Japan

  3. 3

    Department of Functional Genomics, Graduate School of Medicine, Chiba University, Chiba, Japan

  4. 4

    Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan

  5. 5

    Research Center for Emerging Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan

  1. †

    Department of Immunology, Immunobiology Research Institute, Chiron, Siena, Italy

*Department of Virology II, National Institute of Infectious Diseases, 1–23–1, Toyama, Shinjuku-ku, Tokyo, 162–8640, Japan. fax: (81) 3–5285–1161

Publication History

  1. Issue published online: 7 MAR 2007
  2. Article first published online: 7 MAR 2007
  3. Manuscript Accepted: 1 SEP 2002
  4. Manuscript Received: 2 MAY 2002

Funded by

  • Ministry of Health and Welfare and the Organization for Pharmaceutical Safety and Research, Japan

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (857K)

Reference

  • 1
    Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–362.
  • 2
    Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–364.
  • 3
    Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 1990; 87: 6547–6549.
  • 4
    Lai MMC, Ware CF: Hepatitis C virus core protein: possible rules in viral pathogenesis. In: HagedornCH, RiceCM, eds. The Hepatitis C Viruses. Heidelberg: Springer, 1999: 117–134.
  • 5
    Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065–1067.
  • 6
    Houghton M, Selby M, Weiner A, Choo QL. Hepatitis C virus: structure, protein products, and processing of the polyprotein precursor. Curr Stud Hematol Blood Transfus 1994; 61: 1–11.
  • 7
    Ruggieri A, Harada T, Matsuura Y, Miyamura T. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 1997; 229: 68–76.
  • 8
    Harada T, Kim DW, Sagawa K, Suzuki T, Takahashi K, Saito I, Matsuura Y, et al. Characterization of an established human hepatoma cell line constitutively expressing non-structural proteins of hepatitis C virus by transfection of viral cDNA. J Gen Virol 1995; 76: 1215–1221.
  • 9
    Huang Y, Uchiyama Y, Fujimura T, Kanamori H, Doi T, Takamizawa A, Hamakubo T, et al. A human hepatoma cell line expressing hepatitis C virus nonstructural proteins tightly regulated by tetracycline. Biochem Biophys Res Commun 2001; 281: 732–740.
  • 10
    Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110–113.
  • 11
    Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290: 1972–1974.
  • 12
    Ikeda M, Yi M, Li K, Lemon SM. Selectable subgenomic and genomelength dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 2002; 76: 2997–3006.
  • 13
    Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G. Rutter G, Strand D, et al. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 2002; 76: 4008–4021.
  • 14
    Aizaki H, Aoki Y, Harada T, Ishii K, Suzuki T, Nagamori S, Toda G, et al. Full-length complementary DNA of hepatitis C virus genome from an infectious blood sample. Hepatology 1998; 27: 621–627.
    Direct Link:
  • 15
    Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A 1997; 94: 1200–1205.
  • 16
    Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193–199.
  • 17
    Schwartz AL, Fridovich SE, Knowles BB, Lodish HF. Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J Biol Chem 1981; 256: 8878–8881.
  • 18
    Kim DW, Uetsuki T, Kaziro Y, Yamaguchi N, Sugano S. Use of the human elongation factor 1 α promoter as a versatile and efficient expression system. Gene 1990; 91: 217–223.
  • 19
    Aizaki H, Saito S, Ogino T, Miyajima N, Harada T, Matsuura Y, Miyamura T, et al. Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins. J Interferon Cytokine Res 2000; 20: 1111–1120.
  • 20
    Suzuki R, Matsuura Y, Suzuki T, Ando A, Chiba J, Harada S. Saito I, et al. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted. J Gen Virol 1995; 76: 53–61.
  • 21
    Suzuki T, Sato M, Chieda S, Shoji I, Harada T, Yamakawa Y, Warabe S, et al. In vivo and in vitro trans-cleavage activity of hepatitis C virus serine proteinase expressed by recombinant baculoviruses. J Gen Virol 1995; 76: 3021–3029.
  • 22
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685.
  • 23
    Sugano S, Kim DW, Yu YS, Mizushima-Sugano J, Yoshitomo K, Watanabe K, Suzuki F, et al. Use of an epitope-tagged cDNA library to isolate cDNAs encoding proteins with nuclear localization potential. Gene 1992; 120: 227–233.
  • 24
    Aoyagi K, Ohue C, Lida K, Kimura T, Tanaka E, Kiyosawa K, Yagi S. Development of a simple and highly sensitive enzyme immenoassay for virus core antigen. J Clin Microbiol 1999; 37: 1802–1808.
  • 25
    Otsuka M, Kato M, Yoshikawa T, Chen H, Brown EJ, Masuho Y, Omata M, Seki N. Differential expression of the L-plastin gene in human colorectal cancer progression and metastasis. Biochem Biophys Res Commun 2002; (in press).
  • 26
    Yoshikawa T, Nagasugi Y, Azuma T, Kato M, Sugano S, Hashimoto K, Masuho Y, et al. Isolation of novel mouse genes differentially expressed in brain using cDNA microarray. Biochem Biophys Res Commun 2000; 275: 532–537.
  • 27
    Aizaki H. Expression of a full-length hepatitis C virus cDNA by a recombinant baculovirus. Tokyo Jikeikai Med J 1998; 113: 553–562.
  • 28
    Moradpour D, Wakita T, Wands JR, Blum HE. Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines. Biochem Biophys Res Commun 1998; 246: 920–924.
  • 29
    Honda M, Kaneko S, Kawai H, Shirota Y, Kobayashi K. Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 2001; 120: 955–966.
  • 30
    Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001; 75: 7059–7066.
  • 31
    Kaufmann E, Knochel W. Five years on the wings of fork head. Mech Dev 1996; 57: 3–20.
  • 32
    Chen X, Rubock MJ, Whitman M. A transcriptional partner for MAD proteins in TGF-β signalling. Nature 1996; 383: 691–696.
  • 33
    Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, Ruvkun G. The fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 1997; 389: 994–999.
  • 34
    Galili G, Kawata EE, Smith LD, Larkins BA. Role of the 3-poly (A) sequence in translational regulation of mRNAs in Xenopus laevis oocytes. J Biol Chem 1988; 263: 5764–5770.
  • 35
    Minvielle-Sebastia L, Preker PJ, Wiederkehr T, Strahm Y, Keller W. The major yeast poly (A)-binding protein is associated with cleavage factor IA and functions in premessenger RNA 3-end formation. Proc Natl Acad Sci U S A 1997; 94: 7897–7902.
  • 36
    Cutler ML, Bassin RH, Zanoni L, Talbot N. Isolation of rsp-1, a novel cDNA capable of suppressing v-Ras transformation. Mol Cell Biol 1992; 12: 3750–3756.
  • 37
    Masuelli L, Ettenberg S, Vasaturo F, Vestergaard-Sykes K, Cutler ML. The ras suppresor, RSU-1, enhances nerve growth factor-induced differentiation of PC12 cells and induces p21CIP expression. Cell Growth Differ 1999; 10: 555–564.
  • 38
    Montano L, Miescher GC, Goodall AH, Wiedmann KH, Janossy G, Thomas HC. Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection. Hepatology 1982; 2: 557–561.
    Direct Link:
  • 39
    Sung CH, Hu CP, Hsu HC, Ng AK, Chou CK, Ting LP, Su TS, et al. Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma. J Clin Invest 1989; 83: 421–429.
  • 40
    Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149: 3339–3344.
  • 41
    Shirai M, Okada H, Nishioka M, Akatsuka T, Wychowski C, Houghten R, Pendleton CD, et al. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 1994; 68: 3334–3342.
  • 42
    Moradpour D, Grabscheid B, Kammer AR, Schmidtke G, Groettrup M, Blum HE, Cerny A. Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro. Hepatology 2001; 33: 1282–1287.
    Direct Link:
  • 43
    Shirota Y, Kaneko S, Honda M, Kawai HF, Kobayashi K. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 2001; 33: 832–840.
    Direct Link:
  • 44
    Bost F, Diarra-Mehrpour M, Martin JP. Inter-α-typsin inhibitor proteoglycan family—a group of proteins binding and stabilizing the extracellular matrix. Eur J Biochem 1998; 252: 339–346.
    Direct Link:
  • 45
    Tamura Y, Peng P, Liu K, Daou M, Srivastava PK. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 1997; 278: 117–120.
  • 46
    Udono H, Levey DL, Srivastava PK. Cellular requirements for tumorspecific immunity elicited by heat shock proteins: rumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc Natl Acad Sci U S A 1994; 91: 3077–3081.
Get PDF (857K)